Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating balovaptan for efficacy and safety in adults with post-traumatic stress disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Balovaptan (balovaptan)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: COMPLETED | Results posted: 2024-04-18